BPR1K871 is a potent and selective dual FLT3/AURKA inhibitor with IC50s of 19 nM and 22 nM for FLT3 and AURKA, respectively, acts as a preclinical development candidate for anti-cancer therapy[1].
Molecular Weight:
526.05
Purity:
99.12
CAS Number:
[2443767-35-7]
Formula:
C25H28ClN7O2S
Target:
FLT3
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted